zhiqun zhou
University of Miami
H-index: 10
North America-United States
Top articles of zhiqun zhou
Tumor Cell–Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer
Cancer Research
2024/4/15
CREB activation drives acinar to ductal reprogramming and promote pancreatic cancer progression in animal models of alcoholic chronic pancreatitis
bioRxiv
2024
Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer
Cancer discovery
2023/6/2
Tumor cell-macrophage crosstalk drives immune suppression in pancreatic cancer
Cancer Research
2023/4/4
Inhibition of tumor cell-autonomous p38 MAPK suppresses IL1α-mediated inflammatory tumor-stromal crosstalk in pancreatic adenocarcinoma
Cancer Research
2023/4/4
Anna Bianchi
H-Index: 1
Zhiqun Zhou
H-Index: 7
Jashodeep Datta
H-Index: 21
Nagaraj Nagathihalli
H-Index: 17
Remodeling of stromal immune microenvironment by urolithin A improves survival with immune checkpoint blockade in pancreatic cancer
Cancer research communications
2023/7/12
Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy …
Gastroenterology
2022/12/1
Abstract C059: Targeting tumor intrinsic p38 MAPK signaling to block IL-1α-mediated inflammatory tumor-stromal crosstalk in pancreatic cancer
Cancer Research
2022/11/15
Anna Bianchi
H-Index: 1
Zhiqun Zhou
H-Index: 7
Nagaraj Nagathihalli
H-Index: 17
Jashodeep Datta
H-Index: 21
Neutrophil Attenuation Improves Chemosensitivity by Mitigating Inflammatory Polarization of Cancer-Associated Fibroblasts in Pancreatic Cancer
Journal of the American College of Surgeons
2022/11/1
Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signaling
American Journal of Physiology-Gastrointestinal and Liver Physiology
2022/10/1
Deciphering the role of CREB1 in shaping the tumor immune landscape of pancreatic ductal adenocarcinoma
Cancer Research
2022/6/15
Targeting stromal-specific p38 MAPK signaling to stifle inflammatory reprogramming of cancer-associated fibroblasts in pancreatic cancer
Cancer Research
2022/6/15
DOT1L is a novel cancer stem cell target for triple-negative breast cancer
Clinical cancer research
2022/5/2
Combined MEK and STAT3 inhibition reprograms stromal inflammation to overcome immunotherapy resistance in pancreatic cancer
bioRxiv
2021/3/8